Delivery method
Subcutaneous Injection
Lower-dose direct NAD+ route used in some supervised home protocols.
Subcutaneous injection of NAD+ offers an alternative to IV for patients who need frequent, lower doses. In practice it is often associated with clinician-directed compounded protocols rather than mainstream retail products. Onset is slower than IV, but administration risk is lower.